China Blood-based Biomaker For Sports Medicine Market Size & Outlook
China blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
China blood-based biomaker for sports medicine market highlights
- The China blood-based biomaker for sports medicine market generated a revenue of USD 36.2 million in 2023 and is expected to reach USD 69.0 million by 2030.
- The China market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 36.2 million |
| Market revenue in 2030 | USD 69.0 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, China accounted for 5.4% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 17.96% in 2023. Horizon Databook has segmented the China blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
China’s sports industry is rapidly expanding, fueled by rising participation and substantial government investment in promoting physical activity & athletic excellence. This growth has intensified the focus on athlete health and performance, driving the demand for advanced medical technologies like bloodbased biomarkers.
The Chinese government has set an ambitious target to grow the sports industry to USD 699.52 billion by 2025, highlighting a promising future for the sector and emphasizing the need for cutting-edge health & performance monitoring tools.
Moreover, China is witnessing a rise in sports-related injuries, driven by the increasing number of individuals participating in athletic activities. According to a February 2024 report, the incidence of sports injuries in China reached a high of 87.10%, with athletes experiencing an average of 3.39 yearly injuries.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
China Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
